Deep EigenMatics, Inc., a pioneer in high-velocity Artificial Intelligence for drug design, announced today that it has ...

At Web Summit Qatar, AI-powered biotech startups describe how automation, data, and gene editing are filling labor gaps in ...

Microsoft develops a lightweight scanner that detects backdoors in open-weight LLMs using three behavioral signals, improving ...

Explore the complexities of tauopathies and how new research could change their diagnosis and treatment approaches.

A team from the Faculty of Medicine and Health Sciences and the Institute of Neurosciences at the University of Barcelona ...

Google DeepMind released AlphaGenome on January 28, an AI model that predicts how DNA sequences translate into biological functions, processing up to one million base-pairs at once and outperforming ...

A team from the Faculty of Medicine and Health Sciences and the Institute of Neurosciences at the University of Barcelona (UBneuro) has applied advanced artificial intelligence techniques to better ...

AI: How does this technological revolution fit with the pharmaceutical regulators who oversee the pharmaceutical sector at ...

AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...

Although large language models (LLMs) have the potential to transform biomedical research, their ability to reason accurately across complex, data-rich domains remains unproven. To address this ...

Discover how researchers are overcoming the limitations of the undruggable target in drug discovery using novel approaches ...